These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12840524)

  • 1. Pharmacological probes for protein kinase C: an introduction.
    Kazanietz MG
    Methods Mol Biol; 2003; 233():389-95. PubMed ID: 12840524
    [No Abstract]   [Full Text] [Related]  

  • 2. Phorbol esters as probes for the study of protein kinase C function.
    Kazanietz MG; Lorenzo PS
    Methods Mol Biol; 2003; 233():423-39. PubMed ID: 12840526
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein kinase C intervention: the state of play.
    Roffey J; Rosse C; Linch M; Hibbert A; McDonald NQ; Parker PJ
    Curr Opin Cell Biol; 2009 Apr; 21(2):268-79. PubMed ID: 19233632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of inhibitors for protein kinase C and their isoforms.
    Shen GX; Way KJ; Jacobs JR; King GL
    Methods Mol Biol; 2003; 233():397-422. PubMed ID: 12840525
    [No Abstract]   [Full Text] [Related]  

  • 5. Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic.
    Budas GR; Koyanagi T; Churchill EN; Mochly-Rosen D
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1021-6. PubMed ID: 17956268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the interaction of protein kinase C with membranes: an introduction.
    Newton AC
    Methods Mol Biol; 2003; 233():89-92. PubMed ID: 12840500
    [No Abstract]   [Full Text] [Related]  

  • 7. Complexities in protein kinase C activity assays: an introduction.
    Sando JJ
    Methods Mol Biol; 2003; 233():45-61. PubMed ID: 12840497
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic approaches to studying protein kinase C: an introduction.
    Messing RO
    Methods Mol Biol; 2003; 233():453-4. PubMed ID: 12840528
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystallization of the protein kinase Cdelta C1B domain.
    Zhang G; Hurley JH
    Methods Mol Biol; 2003; 233():299-304. PubMed ID: 12840517
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH.
    Selvatici R; Falzarano S; Franceschetti L; Mollica A; Guerrini R; Siniscalchi A; Spisani S
    FEBS J; 2008 Feb; 275(3):449-57. PubMed ID: 18167144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of protein kinase C: an introduction.
    Hurley JH
    Methods Mol Biol; 2003; 233():289-90. PubMed ID: 12840515
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel functions of the phospholipase D2-Phox homology domain in protein kinase Czeta activation.
    Kim JH; Kim JH; Ohba M; Suh PG; Ryu SH
    Mol Cell Biol; 2005 Apr; 25(8):3194-208. PubMed ID: 15798205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based optimization of PKCtheta inhibitors.
    Mosyak L; Xu Z; Joseph-McCarthy D; Brooijmans N; Somers W; Chaudhary D
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1027-31. PubMed ID: 17956269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible inactivation of protein kinase C isozymes by thiol-reactive peptide substrate analogs.
    O'Brian CA; Ward NE; Chu F; Stewart JR
    Methods Mol Biol; 2003; 233():441-9. PubMed ID: 12840527
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of protein kinase C theta activation loop autophosphorylation and the kinase domain catalytic mechanism.
    Czerwinski R; Aulabaugh A; Greco RM; Olland S; Malakian K; Wolfrom S; Lin L; Kriz R; Stahl M; Huang Y; Liu L; Chaudhary D
    Biochemistry; 2005 Jul; 44(28):9563-73. PubMed ID: 16008341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-5 Substituted heteroaryl 3-pyridinecarbonitriles as PKCtheta inhibitors: Part I.
    Subrath J; Wang D; Wu B; Niu C; Boschelli DH; Lee J; Yang X; Brennan A; Chaudhary D
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5423-5. PubMed ID: 19682896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of atypical protein kinase C isotypes to the drug discovery process.
    Jenny M; Wrulich OA; Schwaiger W; Ueberall F
    Chembiochem; 2005 Mar; 6(3):491-9. PubMed ID: 15712318
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathway illuminated: visualizing protein kinase C signaling.
    Violin JD; Newton AC
    IUBMB Life; 2003 Dec; 55(12):653-60. PubMed ID: 14769001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of 5-phenyl-3-pyridinecarbonitriles as PKCtheta inhibitors.
    Boschelli DH; Wang D; Prashad AS; Subrath J; Wu B; Niu C; Lee J; Yang X; Brennan A; Chaudhary D
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3623-6. PubMed ID: 19447612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms.
    van der Merwe JQ; Moreau F; MacNaughton WK
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1258-66. PubMed ID: 19359428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.